Bellmunt risk score as a survival predictor in patients with metastatic castration-resistant prostate cancer.

Thomas BüttnerNiklas KlümperRichard WeitenPhilipp LossinStefan LatzCarolin JacobsManuel RitterStefan HauserJoerg Ellinger Philipp Krausewitz

Published in: The Prostate (2024)

The Bellmunt risk score is easy to assess and provides useful prognostic information in mCRPC, and can support physicians in their treatment decisions.

Keyphrases

primary care
health information